Sabine Enengl
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sabine Enengl has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
Peter Oppelt
Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria
5 shared publicationsPatrick Stelzl
Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria
3 shared publications- Peter Oppelt
Experimental Gynaecology, Obstetrics and Gynaecological Endocrinology, Johannes Kepler University Linz, Altenberger Strasse 69, 4040 Linz, Austria
3 shared publications Philip Sebastian Trautner
Department of Gynecology, Obstetrics and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University, Linz, Austria
3 shared publicationsJulia Lastinger
Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria
2 shared publicationsOmar Shebl
Department of Gynecology, Obstetrics, and Gynecological Endocrinology, Kepler University Hospital, Johannes Kepler University Linz, Linz, Austria
2 shared publications
Latest Publications
- Open Access
- 6 February 2025
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (02) , 190-199
Risk for Imminent Delivery in Preeclampsia Based on the sFlt-1/PlGF Ratio: Do We Need New Cut-Offs?
It is still difficult to predict the outcome of preeclampsia and determine the individual procedure with regards to the time of birth. Cut-offs of the sFlt-1/PlGF ratio with a high risk for imminent delivery have been previously published and analyzed by our study group, but could not be confirmed. The aim of the current study is to re-evaluate the described cut-off values again in a new period of time.We performed a retrospective analysis (IRB 1279/2020) including all preeclampsia patients delivering in our department over a 3-year period. Patients were divided into 2 groups – gestational week 24+0–33+6 with an s-Flt1/PlGF > 655.2 and 34+0–37+0 weeks with an sFlt-1/PlGF > 201 and were compared with preeclampsia patients of the same weeks with sFlt-1/PlGF values below the described cut-offs. Correlation between sFlt-1/PlGF ratio and time to delivery was assessed.The association between sFlt-1/PlGF above the threshold and delivery within 48 h is significant for the high ratio early group (p < 0.01) but not for the high ratio late group (p = 0.62). In the early group, 60% of patients with sFlt-1/PlGF > 655.2 but only 8% in the low ratio group delivered within 48 h. In both the early and the late preeclampsia group, a high number of patients remained pregnant even though they showed elevated ratios.High sFlt-1/PlGF ratios seem to correlate with a shorter pregnancy duration to some extent. Nevertheless, not all patients need to be delivered within 48 h, so the decision should never be based on the laboratory test alone.
- 6 February 2025
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (02) , 190-199
Open AccessRisk for Imminent Delivery in Preeclampsia Based on the sFlt-1/PlGF Ratio: Do We Need New Cut-Offs?
It is still difficult to predict the outcome of preeclampsia and determine the individual procedure with regards to the time of birth. Cut-offs of the sFlt-1/PlGF ratio with a high risk for imminent delivery have been previously published and analyzed by our study group, but could not be confirmed. The aim of the current study is to re-evaluate the described cut-off values again in a new period of time.We performed a retrospective analysis (IRB 1279/2020) including all preeclampsia patients delivering in our department over a 3-year period. Patients were divided into 2 groups – gestational week 24+0–33+6 with an s-Flt1/PlGF > 655.2 and 34+0–37+0 weeks with an sFlt-1/PlGF > 201 and were compared with preeclampsia patients of the same weeks with sFlt-1/PlGF values below the described cut-offs. Correlation between sFlt-1/PlGF ratio and time to delivery was assessed.The association between sFlt-1/PlGF above the threshold and delivery within 48 h is significant for the high ratio early group (p < 0.01) but not for the high ratio late group (p = 0.62). In the early group, 60% of patients with sFlt-1/PlGF > 655.2 but only 8% in the low ratio group delivered within 48 h. In both the early and the late preeclampsia group, a high number of patients remained pregnant even though they showed elevated ratios.High sFlt-1/PlGF ratios seem to correlate with a shorter pregnancy duration to some extent. Nevertheless, not all patients need to be delivered within 48 h, so the decision should never be based on the laboratory test alone.
- Open Access
- 28 November 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (01) , 47-55
Differences between Current Clinical Practice and Evidence-Based Guideline Recommendations Regarding Tocolysis – an Austria-wide Survey
To evaluate the adherence of Austrian obstetricians to national guideline recommendations by investigating data on the current practice of tocolysis regarding indications, timing and monitoring of tocolysis, choice of tocolytics and serious side effects, maintenance tocolysis, support of decision-making and recommendations at patient’s discharge from the hospital. 78 obstetric departments in Austria were invited to participate in a nationwide survey between June 5th and August 31st 2023 by answering a web-based questionnaire about clinical standards. The survey was conducted approximately one year after implementation of the AWMF Guideline “Prevention and Therapy of Preterm Birth” 015‑025. Collected data were analyzed descriptively by performing measures of frequency. Fisher’s exact test was used for group comparison. The response rate was 69.2% (33.3% perinatal centers, 66.7% standard care). The most important indication of tocolysis were ≥ 4 contractions within 20 minutes of CTG tracing, as stated by 26 (48.1%) of the respondents; the AWMF Guideline 015‑025 (2022) was the most important decision-making support for tocolytic treatment (61.1%). 19 (35.2%) of obstetric units started tocolysis earliest at 23 + 0 weeks of gestation. Atosiban was the first-line tocolytic drug used by 43 (79.6%) of obstetric units, followed by nifedipine (n = 7, 13.0%); 49 of 54 obstetric units (90.7%) stated to perform maintenance tocolysis, among these 46 (93.9%) not routinely but on special indications (e.g. placenta previa). Serious side effects were observed by 77.8% of the respondents, mostly associated with the use of hexoprenaline. Our survey revealed considerable discrepancies between evidence-based guideline recommendations and daily clinical practice in Austrian hospitals. Ziel dieser Studie war es, die Einhaltung von Empfehlungen in nationalen Leitlinien durch Geburtshelfer*innen in Österreich zu bewerten. Dazu wurden Daten zur aktuellen Praxis der Tokolyse hinsichtlich Indikation, Zeitpunkt und Überwachung der Tokolyse, Wahl des Tokolytikums und schwerwiegende Nebenwirkungen, Erhaltungstokolyse, Entscheidungshilfe und Empfehlungen bei Entlassung der Patientin aus dem Krankenhaus untersucht. Zwischen dem 5. Juni und dem 31. August 2023 wurden 78 geburtshilfliche Abteilungen in Österreich zur Teilnahme an einer landesweiten Erhebung aufgefordert, indem sie einen Online-Fragebogen über klinische Standards beantworten sollten. Die Erhebung wurde ungefähr 1 Jahr nach Einführung der AWMF-Leitlinie „Prävention und Therapie der Frühgeburt“ 015‑025 durchgeführt. Die deskriptive Analyse der erhobenen Daten erfolgte mittels Häufigkeitsanalysen. Der Exakte Fisher-Test wurde für Gruppenvergleiche eingesetzt. Die Rücklaufquote betrug 69,2% (33,3% Perinatalzentren, 66,7% Zentren der Grund- und Regelversorgung). Laut 26 (48,1%) der Befragten war die wichtigste Indikation zur Einleitung einer Tokolyse eine CTG-Aufzeichnung von ≥ 4 Wehen/20 Minuten; die AWMF-Leitlinie 015‑025 (2022) stellte die wichtigste Entscheidungshilfe für eine tokolytische Behandlung dar (61,1%). 19 (35,2%) der geburtshilflichen Abteilungen haben frühestens in der 23 + 0 Schwangerschaftswoche mit einer Tokolyse begonnen. Tokolytikum der ersten Wahl war das Mittel Atosiban, das von 43 (79,6%) geburtshilflichen Abteilungen eingesetzt wurde, gefolgt von Nifedipin (n = 7, 13,0%); 49 von 54 geburtshilflichen Abteilungen (90,7%) gaben an, dass sie eine Erhaltungstokolyse verabreichen, wobei 46 (93,9%) diese nicht routinemäßig, sondern nur bei besonderen Indikationen (z. B. Placenta praevia) einsetzen. Schwerwiegende Nebenwirkungen wurden von 77,8% der Umfrageteilnehmer*innen beobachtet, meist in Verbindung mit dem Einsatz von Hexoprenalin. Unsere Erhebung zeigte beträchtliche Diskrepanzen zwischen den evidenzbasierten Empfehlungen der Leitlinie und der täglichen klinischen Praxis in österreichischen Krankenhäusern auf. Received: 16 September 2024 Accepted after revision: 19 October 2024 Article published online: 28 November 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 28 November 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 85 (01) , 47-55
Open AccessDifferences between Current Clinical Practice and Evidence-Based Guideline Recommendations Regarding Tocolysis – an Austria-wide Survey
To evaluate the adherence of Austrian obstetricians to national guideline recommendations by investigating data on the current practice of tocolysis regarding indications, timing and monitoring of tocolysis, choice of tocolytics and serious side effects, maintenance tocolysis, support of decision-making and recommendations at patient’s discharge from the hospital. 78 obstetric departments in Austria were invited to participate in a nationwide survey between June 5th and August 31st 2023 by answering a web-based questionnaire about clinical standards. The survey was conducted approximately one year after implementation of the AWMF Guideline “Prevention and Therapy of Preterm Birth” 015‑025. Collected data were analyzed descriptively by performing measures of frequency. Fisher’s exact test was used for group comparison. The response rate was 69.2% (33.3% perinatal centers, 66.7% standard care). The most important indication of tocolysis were ≥ 4 contractions within 20 minutes of CTG tracing, as stated by 26 (48.1%) of the respondents; the AWMF Guideline 015‑025 (2022) was the most important decision-making support for tocolytic treatment (61.1%). 19 (35.2%) of obstetric units started tocolysis earliest at 23 + 0 weeks of gestation. Atosiban was the first-line tocolytic drug used by 43 (79.6%) of obstetric units, followed by nifedipine (n = 7, 13.0%); 49 of 54 obstetric units (90.7%) stated to perform maintenance tocolysis, among these 46 (93.9%) not routinely but on special indications (e.g. placenta previa). Serious side effects were observed by 77.8% of the respondents, mostly associated with the use of hexoprenaline. Our survey revealed considerable discrepancies between evidence-based guideline recommendations and daily clinical practice in Austrian hospitals. Ziel dieser Studie war es, die Einhaltung von Empfehlungen in nationalen Leitlinien durch Geburtshelfer*innen in Österreich zu bewerten. Dazu wurden Daten zur aktuellen Praxis der Tokolyse hinsichtlich Indikation, Zeitpunkt und Überwachung der Tokolyse, Wahl des Tokolytikums und schwerwiegende Nebenwirkungen, Erhaltungstokolyse, Entscheidungshilfe und Empfehlungen bei Entlassung der Patientin aus dem Krankenhaus untersucht. Zwischen dem 5. Juni und dem 31. August 2023 wurden 78 geburtshilfliche Abteilungen in Österreich zur Teilnahme an einer landesweiten Erhebung aufgefordert, indem sie einen Online-Fragebogen über klinische Standards beantworten sollten. Die Erhebung wurde ungefähr 1 Jahr nach Einführung der AWMF-Leitlinie „Prävention und Therapie der Frühgeburt“ 015‑025 durchgeführt. Die deskriptive Analyse der erhobenen Daten erfolgte mittels Häufigkeitsanalysen. Der Exakte Fisher-Test wurde für Gruppenvergleiche eingesetzt. Die Rücklaufquote betrug 69,2% (33,3% Perinatalzentren, 66,7% Zentren der Grund- und Regelversorgung). Laut 26 (48,1%) der Befragten war die wichtigste Indikation zur Einleitung einer Tokolyse eine CTG-Aufzeichnung von ≥ 4 Wehen/20 Minuten; die AWMF-Leitlinie 015‑025 (2022) stellte die wichtigste Entscheidungshilfe für eine tokolytische Behandlung dar (61,1%). 19 (35,2%) der geburtshilflichen Abteilungen haben frühestens in der 23 + 0 Schwangerschaftswoche mit einer Tokolyse begonnen. Tokolytikum der ersten Wahl war das Mittel Atosiban, das von 43 (79,6%) geburtshilflichen Abteilungen eingesetzt wurde, gefolgt von Nifedipin (n = 7, 13,0%); 49 von 54 geburtshilflichen Abteilungen (90,7%) gaben an, dass sie eine Erhaltungstokolyse verabreichen, wobei 46 (93,9%) diese nicht routinemäßig, sondern nur bei besonderen Indikationen (z. B. Placenta praevia) einsetzen. Schwerwiegende Nebenwirkungen wurden von 77,8% der Umfrageteilnehmer*innen beobachtet, meist in Verbindung mit dem Einsatz von Hexoprenalin. Unsere Erhebung zeigte beträchtliche Diskrepanzen zwischen den evidenzbasierten Empfehlungen der Leitlinie und der täglichen klinischen Praxis in österreichischen Krankenhäusern auf. Received: 16 September 2024 Accepted after revision: 19 October 2024 Article published online: 28 November 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 7 November 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 84 (11) , 1066-1073
Retrospective Evaluation of C-reactive Protein for Ruling Out Infection After Cesarean Section
Infection after cesarean section is a major contributor to maternal morbidity. Measurement of C-reactive protein (CRP) is a laboratory test frequently conducted to rule out or confirm postoperative infection. The present study aimed to evaluate whether CRP is a suitable tool for ruling out infection after cesarean section and whether there are any reliable cut-off values.2056 patients with cesarean section (CS) over a 3-year period were included in a retrospective analysis. Outcome parameters and risk factors for postoperative infection were collected. CRP values from preoperative and postoperative tests were compared. Cut-offs for ruling out infection were assessed.Among 2056 CSs, postoperative infection occurred in 78 cases (3.8%). The prevalence of infection in emergency CS was lowest, at four out of 134 (2.9%), and the highest prevalence was seen in secondary CS, at 42 of 903 (4.6%; p = 0.35). CRP values in the infection group were significantly higher (preoperative, 1.01 mg/dl vs. 0.62 mg/dl; day 1 postoperative, 7.91 mg/dl vs. 6.44 mg/dl; day 4 postoperative, 8.44 mg/dl vs. 4.09 mg/dl; p = 0.01). A suitable cut-off value for ruling out infection was not identified.Although CRP values were significantly higher in the infection group, the clinical relevance of this appears to be negligible. CRP testing does not appear to be a reliable tool for diagnosing or ruling out postoperative infection.
- 7 November 2024
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 84 (11) , 1066-1073
Open AccessRetrospective Evaluation of C-reactive Protein for Ruling Out Infection After Cesarean Section
Infection after cesarean section is a major contributor to maternal morbidity. Measurement of C-reactive protein (CRP) is a laboratory test frequently conducted to rule out or confirm postoperative infection. The present study aimed to evaluate whether CRP is a suitable tool for ruling out infection after cesarean section and whether there are any reliable cut-off values.2056 patients with cesarean section (CS) over a 3-year period were included in a retrospective analysis. Outcome parameters and risk factors for postoperative infection were collected. CRP values from preoperative and postoperative tests were compared. Cut-offs for ruling out infection were assessed.Among 2056 CSs, postoperative infection occurred in 78 cases (3.8%). The prevalence of infection in emergency CS was lowest, at four out of 134 (2.9%), and the highest prevalence was seen in secondary CS, at 42 of 903 (4.6%; p = 0.35). CRP values in the infection group were significantly higher (preoperative, 1.01 mg/dl vs. 0.62 mg/dl; day 1 postoperative, 7.91 mg/dl vs. 6.44 mg/dl; day 4 postoperative, 8.44 mg/dl vs. 4.09 mg/dl; p = 0.01). A suitable cut-off value for ruling out infection was not identified.Although CRP values were significantly higher in the infection group, the clinical relevance of this appears to be negligible. CRP testing does not appear to be a reliable tool for diagnosing or ruling out postoperative infection.
- Open Access
- 30 October 2023
- Published by Springer Nature in Research Square
C-reactive protein is not a reliable marker for ruling out infection after cesarean section: a retrospective analysis
Purpose Infection after cesarean section is a major contributor to maternal morbidity. Measurement of C-reactive protein (CRP) is a laboratory test frequently conducted to rule out or confirm postoperative infection. The present study aimed to evaluate whether CRP is a suitable tool for ruling out infection after cesarean section and whether there are any reliable cut-off values.Methods 2056 patients with cesarean section (CS) over a 3-year period were included in a retrospective analysis. Outcome parameters and risk factors for postoperative infection were collected. CRP values from preoperative and postoperative tests were compared. Cut-offs for ruling out infection were assessed.Results Among 2056 CSs, postoperative infection occurred in 78 cases (3.8%). The prevalence of infection in emergency CS was lowest, at four out of 134 (2.9%), and the highest prevalence was seen in secondary CS, at 42 of 903 (4.6%; P = 0.35). CRP values in the infection group were significantly higher (preoperative, 1.01 mg/dl vs. 0.62 mg/dl; day 1 postoperative, 7.91 mg/dl vs. 6.44 mg/dl; day 4 postoperative, 8.44 mg/dl vs. 4.09 mg/dl; P = 0.01). A suitable cut-off value for ruling out infection was not identified.Conclusions Although CRP values were significantly higher in the infection group, the clinical relevance of this appears to be negligible. CRP testing does not appear to be a reliable tool for diagnosing or ruling out postoperative infection.
- 30 October 2023
- Published by Springer Nature in Research Square
Open AccessC-reactive protein is not a reliable marker for ruling out infection after cesarean section: a retrospective analysis
Purpose Infection after cesarean section is a major contributor to maternal morbidity. Measurement of C-reactive protein (CRP) is a laboratory test frequently conducted to rule out or confirm postoperative infection. The present study aimed to evaluate whether CRP is a suitable tool for ruling out infection after cesarean section and whether there are any reliable cut-off values.Methods 2056 patients with cesarean section (CS) over a 3-year period were included in a retrospective analysis. Outcome parameters and risk factors for postoperative infection were collected. CRP values from preoperative and postoperative tests were compared. Cut-offs for ruling out infection were assessed.Results Among 2056 CSs, postoperative infection occurred in 78 cases (3.8%). The prevalence of infection in emergency CS was lowest, at four out of 134 (2.9%), and the highest prevalence was seen in secondary CS, at 42 of 903 (4.6%; P = 0.35). CRP values in the infection group were significantly higher (preoperative, 1.01 mg/dl vs. 0.62 mg/dl; day 1 postoperative, 7.91 mg/dl vs. 6.44 mg/dl; day 4 postoperative, 8.44 mg/dl vs. 4.09 mg/dl; P = 0.01). A suitable cut-off value for ruling out infection was not identified.Conclusions Although CRP values were significantly higher in the infection group, the clinical relevance of this appears to be negligible. CRP testing does not appear to be a reliable tool for diagnosing or ruling out postoperative infection.
- 30 September 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (10) , e114
Teenage pregnancies in Austria between 2012 and 2020 – prevalence and obstetric outcome
Introduction Despite declining rates during the last decades, the global prevalence of teenage pregnancies remains high. The rates of peripartal complications, including lower birth weight, lower Apgar-Scores and preterm birth etc., are higher in very young mothers compared to adult mothers. The objective of this study is to evaluate the prevalence of teenage pregnancies in Austria and to identify principal differences in maternal and fetal outcome. Materials and methods Data of 751.661 documented deliveries were obtained from the Austrian Birth Registry. Mothers were categorized into three age groups: below 15, 15 to 19 and above 19 years. Results The offspring of teenage mothers had a significantly lower birthweight (2998 ± 683 vs. 3220 ± 559 vs. 3309 ± 569 g, p < 0.001) than those of adult mothers and was born significantly earlier (38.1 ± 3.4 vs. 38.8 ± 2.2 vs. 38.8 ± 2.1 SSW, p < 0.001). The younger the age of the mother, the lower was the rate of cesarean deliveries (20.4% vs. 21.2% vs. 3.5%, p < 0.001) and the more often an episiotomy was performed during vaginal delivery (14.3% vs. 13.7% vs. 10.2%, p < 0.001). The highest rate of tobacco use was found in the youngest age group (22.4 vs. 22.8 vs. 6.6%, p < 0.001). Conclusion Even though the Austrian healthcare system belongs to the globally best performing systems, the present data show significantly higher adverse outcomes in pregnancies of teenagers compared to adult women. Future guideline recommendations should focus on relevant aspects in obstetric care of teenage mothers. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- 30 September 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (10) , e114
Teenage pregnancies in Austria between 2012 and 2020 – prevalence and obstetric outcome
Introduction Despite declining rates during the last decades, the global prevalence of teenage pregnancies remains high. The rates of peripartal complications, including lower birth weight, lower Apgar-Scores and preterm birth etc., are higher in very young mothers compared to adult mothers. The objective of this study is to evaluate the prevalence of teenage pregnancies in Austria and to identify principal differences in maternal and fetal outcome. Materials and methods Data of 751.661 documented deliveries were obtained from the Austrian Birth Registry. Mothers were categorized into three age groups: below 15, 15 to 19 and above 19 years. Results The offspring of teenage mothers had a significantly lower birthweight (2998 ± 683 vs. 3220 ± 559 vs. 3309 ± 569 g, p < 0.001) than those of adult mothers and was born significantly earlier (38.1 ± 3.4 vs. 38.8 ± 2.2 vs. 38.8 ± 2.1 SSW, p < 0.001). The younger the age of the mother, the lower was the rate of cesarean deliveries (20.4% vs. 21.2% vs. 3.5%, p < 0.001) and the more often an episiotomy was performed during vaginal delivery (14.3% vs. 13.7% vs. 10.2%, p < 0.001). The highest rate of tobacco use was found in the youngest age group (22.4 vs. 22.8 vs. 6.6%, p < 0.001). Conclusion Even though the Austrian healthcare system belongs to the globally best performing systems, the present data show significantly higher adverse outcomes in pregnancies of teenagers compared to adult women. Future guideline recommendations should focus on relevant aspects in obstetric care of teenage mothers. Article published online: 11 October 2022 © 2022. Thieme. All rights reserved. Georg Thieme Verlag Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 6 May 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (05) , 501-509
Antibody Response and Maternofetal Antibody Transfer in SARS-CoV-2-Positive Pregnant Women: A Multicenter Observational Study
Introduction Awareness of SARS-CoV-2 infection in pregnant women and the potential risk for infection of their neonates is increasing. The aim of this study was to examine the immune status of affected women and evaluate the dynamics of placental antibody transfer. Materials and Methods The study included 176 women with SARS-CoV-2 infection during pregnancy who delivered between April 2020 and December 2021 at eight obstetric maternity sites. Demographic data, maternal and neonatal characteristics were summarized. Antibody testing for IgA and IgG in maternal blood sera and umbilical cord samples was evaluated and IgG transfer ratios were calculated. Values were related to the time of infection during pregnancy and birth. Results The percentage of IgG positive women increased from 29.0% (95% CI 23.8 – 37.8) at presentation with a positive PCR test result to 75.7% (95% CI 71.6 – 79.8), the percentage of IgG positive umbilical cord blood samples increased from 17.1% (95% CI 13.0 – 21.3) to 76.4% (95% CI 72.2 – 80.7) at more than six weeks after infection. Regression lines differed significantly between maternal and fetal IgG responses (p < 0.0001). Newborns react with a latency of about one week; umbilical cord blood antibody concentrations are highly correlated with maternal concentration levels (ρ = 0.8042; p < 0.0001). IgG transplacental transfer ratios were dependent on infection-to-birth interval. Two of the umbilical cord blood samples tested positive for IgA. Conclusions These findings confirm vertical SARS-CoV-2 transmission is rare; however, antibodies are transferred to the fetus soon after infection during pregnancy. Since transplacental antibody transfer might have a protective value for neonatal immunization this information may be helpful when counseling affected women.
- 6 May 2022
- Published by Georg Thieme Verlag KG in Geburtshilfe und Frauenheilkunde
- Vol. 82 (05) , 501-509
Open AccessAntibody Response and Maternofetal Antibody Transfer in SARS-CoV-2-Positive Pregnant Women: A Multicenter Observational Study
Introduction Awareness of SARS-CoV-2 infection in pregnant women and the potential risk for infection of their neonates is increasing. The aim of this study was to examine the immune status of affected women and evaluate the dynamics of placental antibody transfer. Materials and Methods The study included 176 women with SARS-CoV-2 infection during pregnancy who delivered between April 2020 and December 2021 at eight obstetric maternity sites. Demographic data, maternal and neonatal characteristics were summarized. Antibody testing for IgA and IgG in maternal blood sera and umbilical cord samples was evaluated and IgG transfer ratios were calculated. Values were related to the time of infection during pregnancy and birth. Results The percentage of IgG positive women increased from 29.0% (95% CI 23.8 – 37.8) at presentation with a positive PCR test result to 75.7% (95% CI 71.6 – 79.8), the percentage of IgG positive umbilical cord blood samples increased from 17.1% (95% CI 13.0 – 21.3) to 76.4% (95% CI 72.2 – 80.7) at more than six weeks after infection. Regression lines differed significantly between maternal and fetal IgG responses (p < 0.0001). Newborns react with a latency of about one week; umbilical cord blood antibody concentrations are highly correlated with maternal concentration levels (ρ = 0.8042; p < 0.0001). IgG transplacental transfer ratios were dependent on infection-to-birth interval. Two of the umbilical cord blood samples tested positive for IgA. Conclusions These findings confirm vertical SARS-CoV-2 transmission is rare; however, antibodies are transferred to the fetus soon after infection during pregnancy. Since transplacental antibody transfer might have a protective value for neonatal immunization this information may be helpful when counseling affected women.
- Open Access
- 10 January 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 270, 133-138
Do obstetric units adhere to the evidence-based national guideline? A Germany-wide survey on the current practice of initial tocolysis
- 10 January 2022
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 270, 133-138
Open AccessDo obstetric units adhere to the evidence-based national guideline? A Germany-wide survey on the current practice of initial tocolysis
- Open Access
- 21 November 2020
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 303 (6) , 1461-1468
Retrospective evaluation of attempted vaginal deliveries in dichorionic twin pregnancies
Purpose: Numbers of planned cesarean deliveries are increasing in twin pregnancies, despite the lack of evidence for this approach, and the second twin is thought to be at risk for a poorer outcome. The aim of this study was to examine whether twins have a poorer outcome if an attempted vaginal delivery is changed to a cesarean section or combined delivery.Methods: This retrospective data analysis included all women with dichorionic twin pregnancies attempting vaginal delivery over a 10-year period. Outcome parameters for the first and second twins relative to their mode of birth were compared. A correlation model between the interdelivery time interval and Apgar scores was calculated. Subgroup analyses assessing the birth mode of the first and second twins were conducted.Results: A total of 248 women were enrolled in the study. The second twins had significantly lower values for outcome parameters, such as umbilical artery cord pH and Apgar scores in comparison with the first twins (P < 0.01). The subgroup analysis of birth modes in first and second twins showed a significantly poorer outcome in the cesarean section and combined delivery group (P < 0.05). The interdelivery time interval was significantly longer in the second twin cesarean section group (P < 0.01). There was no significant correlation between the interdelivery time intervals and Apgar scores (P > 0.05).Conclusion: Although outcome parameters were significantly lower in second twins and twins born via secondary cesarean section, the clinical relevance of this appears to be negligible.
- 21 November 2020
- Published by Springer Nature in Archives of Gynecology and Obstetrics
- Vol. 303 (6) , 1461-1468
Open AccessRetrospective evaluation of attempted vaginal deliveries in dichorionic twin pregnancies
Purpose: Numbers of planned cesarean deliveries are increasing in twin pregnancies, despite the lack of evidence for this approach, and the second twin is thought to be at risk for a poorer outcome. The aim of this study was to examine whether twins have a poorer outcome if an attempted vaginal delivery is changed to a cesarean section or combined delivery.Methods: This retrospective data analysis included all women with dichorionic twin pregnancies attempting vaginal delivery over a 10-year period. Outcome parameters for the first and second twins relative to their mode of birth were compared. A correlation model between the interdelivery time interval and Apgar scores was calculated. Subgroup analyses assessing the birth mode of the first and second twins were conducted.Results: A total of 248 women were enrolled in the study. The second twins had significantly lower values for outcome parameters, such as umbilical artery cord pH and Apgar scores in comparison with the first twins (P < 0.01). The subgroup analysis of birth modes in first and second twins showed a significantly poorer outcome in the cesarean section and combined delivery group (P < 0.05). The interdelivery time interval was significantly longer in the second twin cesarean section group (P < 0.01). There was no significant correlation between the interdelivery time intervals and Apgar scores (P > 0.05).Conclusion: Although outcome parameters were significantly lower in second twins and twins born via secondary cesarean section, the clinical relevance of this appears to be negligible.
- 1 January 2020
- Published by Elsevier in Pregnancy Hypertension
- Vol. 19, 143-149
Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patients
- 1 January 2020
- Published by Elsevier in Pregnancy Hypertension
- Vol. 19, 143-149
Retrospective evaluation of established cut-off values for the sFlt-1/PlGF ratio for predicting imminent delivery in preeclampsia patients